HuGE Literature Finder
Records
1
-
20
| [Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 818-825. Zhao S Y, Xu Z F, Qin T J, Qu S Q, Li C W, Jia Y J, Pan L J, Li B, Gao Q Y, Jiao M, Huang H J, Xiao Z |
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
| A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood advances 2021 Oct . Wang Yu-Hung, Hou Hsin-An, Lin Chien-Chin, Kuo Yuan-Yeh, Yao Chi-Yuan, Hsu Chia-Lang, Tseng Mei-Hsuan, Tsai Cheng-Hong, Peng Yen-Ling, Kao Chein-Jun, Chou Wen-Chien, Tien Hwei-Fa |
| Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| [Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
| NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood advances 2019 3 3 (6): 922-933. Montalban-Bravo Guillermo, Kanagal-Shamanna Rashmi, Sasaki Koji, Patel Keyur, Ganan-Gomez Irene, Jabbour Elias, Kadia Tapan, Ravandi Farhad, DiNardo Courtney, Borthakur Gautham, Takahashi Koichi, Konopleva Marina, Komrokji Rami S, DeZern Amy, Kuzmanovic Teodora, Maciejewski Jaroslaw, Pierce Sherry, Colla Simona, Sekeres Mikkael A, Kantarjian Hagop, Bueso-Ramos Carlos, Garcia-Manero Guiller |
| What biologic factors predict for transformation to AML? Best practice & research. Clinical haematology 2018 11 31 (4): 341-345. Bejar Rafa |
| Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leukemia research 2015 Mar 39 (3): 348-54. Ok Chi Young, Patel Keyur P, Garcia-Manero Guillermo, Routbort Mark J, Fu Bin, Tang Guilin, Goswami Maitrayee, Singh Rajesh, Kanagal-Shamanna Rashmi, Pierce Sherry A, Young Ken H, Kantarjian Hagop M, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
| RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes. Haematologica 2012 Dec 97 (12): 1909-15. Greif Philipp A, Konstandin Nikola P, Metzeler Klaus H, Herold Tobias, Pasalic Zlatana, Ksienzyk Bianka, Dufour Annika, Schneider Friederike, Schneider Stephanie, Kakadia Purvi M, Braess Jan, Sauerland Maria Cristina, Berdel Wolfgang E, Büchner Thomas, Woermann Bernhard J, Hiddemann Wolfgang, Spiekermann Karsten, Bohlander Stefan |
| ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes, chromosomes & cancer 2012 Apr 51 (4): 328-37. Haferlach Claudia, Bacher Ulrike, Schnittger Susanne, Alpermann Tamara, Zenger Melanie, Kern Wolfgang, Haferlach Torst |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotype. Haematologica 2011 May 96 (5): 784-5. Ammatuna Emanuele, Panetta Paola, Agirre Xabier, Ottone Tiziana, Lavorgna Serena, Calasanz Maria José, Lo-Coco Frances |
| FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia. American journal of clinical pathology 2011 Jan 135 (1): 62-9. Bains Ashish, Luthra Rajyalakshmi, Medeiros L Jeffrey, Zuo Zhua |
| Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms. Leukemia 2011 1 25 (4): 615-21. Schnittger S, Bacher U, Haferlach C, Alpermann T, Dicker F, Sundermann J, Kern W, Haferlach |
| Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes. Clinics (São Paulo, Brazil) 2011 66 (5): 793-9. Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal |
| [Study on NPM1 gene mutations in patients with primary myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2010 Dec 31 (12): 809-812. Li Lin, Zhang Yue, Ma Xiao-Tang, Yang Lin, Xu Ze-Feng, Xiao Zhi-Ji |
| ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
| IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010 Oct 95 (10): 1668-74. Thol Felicitas, Weissinger Eva M, Krauter Jürgen, Wagner Katharina, Damm Frederik, Wichmann Martin, Göhring Gudrun, Schumann Christiane, Bug Gesine, Ottmann Oliver, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: